Epidemiology

Everywhere Chemical Exposure

March 25, 2024

Stephanie Engel uses scans of children’s brains to study the developmental effects of chemicals widely used in plastic products called phthalates.

A Mother’s Wisdom

March 17, 2023

Childhood lessons about identity and self-worth inspire Ganga Bey to address how inequitable social environments affect our health — and how to change that.

Approaching Epidemiology with Empathy

March 14, 2023

Marc Emerson’s experiences growing up in Navajo Nation guide his research on health equity in American Indian and Alaskan Native communities.

Ganga Bey

August 4, 2021

Ganga Bey is a postdoctoral researcher in the Department of Epidemiology within the UNC Gillings School of Global Public Health and a fellow in the Carolina Postdoctoral Program for Faculty Diversity. She studies how people’s beliefs about identity, worth, and ability affect their stress, aging, and susceptibility to disease.

READDI, Not Reactive

January 19, 2021

For decades, scientists warned of the potential for a global coronavirus outbreak. But when SARS-CoV-2 emerged, no therapeutics, drugs, or vaccines were readily available. The Rapidly Emerging Antiviral Drug Development Initiative (READDI) — founded by researchers at UNC and the Structural Genomics Consortium — is not only finding solutions to the COVID-19 pandemic, but also drugs and therapeutics for future viral outbreaks.

Helping the Hardest Hit

September 22, 2020

While the novel coronavirus has affected us all, it has drastically changed the lives of specific groups of people, from rural populations to long-term care residents to communities of color. Startling statistics among these groups have pushed UNC researchers from a variety of disciplines into action.

Expecting the Unexpected

July 7, 2020

After Myron Cohen watched the first patient at UNC Hospitals die from AIDS in 1982, he knew it was a disease to be reckoned with. He spent the next 40 years helping to recruit the most promising infectious disease experts from across the nation to build a program that’s become a leader in HIV. Today, UNC excels in understanding all aspects of HIV, from prevention to a potential cure — expertise that is now being used to tackle COVID-19.